A new treatment may prolong the lifespan of melanoma patients. Vemurafenib, the first acute melanoma drug in more than a…
Rigor acadêmico, estilo jornalístico
Todos os artigos de Melanoma
Exibindo 61 - 61 de 61 artigo
Principais colaboradores
-
Professor of Dermatology, The University of Queensland
-
PhD Candidate, Dermatology Research Centre, The University of Queensland
-
Adjunct Professor, School of Psychology, Curtin University and College of Health and Medicine, Australian National University
-
Professor and Group Leader at the Cancer Control Group, QIMR Berghofer Medical Research Institute
-
Senior Research Officer, Blood Cells and Blood Cancer Division, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Senior Research Officer, Blood Cells and Blood Cancer, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Professor, Department of Biomedical and Life Sciences, Lancaster University
-
Assistant Professor of Systems Biology and Cancer Metabolism, University of California, Merced
-
Chief Specialist Scientist (Public Health), South African Medical Research Council
-
Assistant Professor of Internal Medicine (Division of Dermatology), The University of Texas at Austin
-
Professor in Behavioural Science, The University of Queensland
-
Professor and Director Academic Excellence, Macquarie University
-
Emeritus Professor of Medicine, Monash University
-
Zebrafish Cancer Genetics Research Assistant, Penn State
-
Wellcome Trust Research Fellow, Institute of Cancer Research, London
